Magic bullets for insomnia? Patients' use and experiences of newer (Z drugs) versus older (benzodiazepine) hypnotics for sleep problems in primary care.
نویسندگان
چکیده
BACKGROUND Little is known about patients' perceptions of newer hypnotics. AIM To investigate use, experience, and perceptions of Z drug and benzodiazepine hypnotics in the community. DESIGN OF STUDY Cross-sectional survey of general practice patients who had received at least one prescription for a Z drug or benzodiazepine in the previous 6 months. SETTING Lincolnshire, UK. METHOD Self-administered postal questionnaire. RESULTS Of 1600 surveys posted, 935 (58.4%) responses were received, of which 705 (75.4%) were from patients taking drugs for insomnia. Of those 705 patients, 87.9% (n = 620) were first prescribed a hypnotic by their GP, and 94.9% (n = 669) had taken a sleeping tablet for 4 weeks or more. At least one side effect was reported in 41.8% (n = 295); 18.6% wished to come off hypnotic medication; and 48.5% had tried to stop treatment. Patients on Z drugs were more likely to express a wish to stop (22.7% versus 12.3%; odds ratio [OR] = 1.67, 95% confidence interval [CI] = 1.13 to 2.49), or to have attempted to come off medication, than those on benzodiazepines (52.4% versus 41.0%; OR = 1.54, 95% CI = 1.12 to 2.12). The two groups did not differ significantly in respect of benefits or adverse effects. CONCLUSION There were no significant differences in patients' perceptions of efficacy or side-effects reported by those on Z drugs compared to patients taking benzodiazepines. Side-effects were commonly reported, which may have contributed to a high proportion of responders, particularly patients on Z drugs who were wishing to stop, or who had previously tried to stop taking this medication. Reported prescribing practices were often at variance with the licence for short-term use.
منابع مشابه
Multimorbidity and use of hypnotic and anxiolytic drugs: cross-sectional and follow-up study in primary healthcare in Iceland
BACKGROUND The prevalence of multimorbidity is increasing worldwide, presumably leading to an increased use of medicines. During the last decades the use of hypnotic and anxiolytic benzodiazepine derivatives and related drugs has increased dramatically. These drugs are frequently prescribed for people with a sleep disorder often merely designated as "insomnia" in the medical records and lacking...
متن کاملInappropriate benzodiazepine use in elderly patients and its reduction.
A 72-year old woman with a psychiatric history of anxious depression and insomnia is receiving ongoing psychotherapy and psychotropic management. Her mood disorder has been stable with escitalopram (10 mg/d) for 3 years. She has been taking lorazepam (1 mg nightly) since the death of her husband 12 years ago. Recent research about chronic benzodiazepine therapy leading to an increased risk of A...
متن کاملRapid Publication Sleep Disturbance Is the Most Common Symp- Tom of Mental Illness, Being More Common than Worry and Twice as Common as Anxiety
SLEEP DISTURBANCE IS THE MOST COMMON SYMPTOM OF MENTAL ILLNESS, BEING MORE COMMON THAN WORRY AND TWICE AS COMMON AS ANXIETY or depressive symptoms. Moreover, in a recent UK psychiatric morbidity study,1 this finding held for men and women of any age or ethnic group in any region. Epidemiologic studies report the prevalence of insomnia disorder at 10% to 12%, with older adult rates at greater th...
متن کاملResidual Effects of Short Half-life Non-benzodiazepine Hypnotics
Background Since their introduction at the beginning of the 1990s the short half-life nonbenzodiazepine hypnotics, zolpidem and zopiclone, rapidly were among the most frequently prescribed hypnotics. Surveys showed that around 1996 the most frequently prescribed hypnotic in the US was zolpidem, while zolpidem and zopiclone were among the five most frequently used hypnotics in Europe [1, 2]. The...
متن کاملTreatment of insomnia in older adults: re-evaluating the benefits and risks of sedative hypnotic agents.
Insomnia and sleep complaints are common among older adults. Although once considered safer than benzodiazepine drugs, recent data on non-benzodiazepine drugs, such as zolpidem (Ambien(®)), have revealed similar negative effects. This issue, as well as others, has been included in the recent updated 2012 American Geriatrics Society Beers Criteria. This article describes the risks and benefits a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- The British journal of general practice : the journal of the Royal College of General Practitioners
دوره 58 551 شماره
صفحات -
تاریخ انتشار 2008